SCIENTIFIC-CONFERENCES ON PROBLEMS OF EXPERIMENTAL AND CLINICAL-STUDY OF CARMINOMYCIN, AN ANTI-TUMOR ANTIBIOTIC

被引：0
|
作者：
USPENSKAYA, TA
机构：
来源：
ANTIBIOTIKI | 1978年 / 23卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：854 / 857
页数：4
相关论文
共 50 条
  • [31] Preclinical anti-tumor study of henatinib, a novel and selective inhibitor of VEGFR-2 in phase I clinical trials
    Quan, Haitian
    Xie Chengying
    Xu, Yongping
    Lou Liguang
    CANCER RESEARCH, 2011, 71
  • [32] Basic and clinical study of increased effect of partial anti-tumor agents by infusing sodium bicarbonate through target artery
    Pingsheng Fan
    Chinese-German Journal of Clinical Oncology, 2007, (01) : 13 - 17
  • [33] Clinical Study on The Blood Pressure Changes in Patients with VEGFR-TKI-induced Hypertension During Anti-tumor Treatment
    Li, Jiaxin
    Yu, Jing
    CIRCULATION, 2024, 150
  • [34] IMMUNOTHERAPY IN CANCER - IN VIVO STUDY OF THE ANTI-TUMOR ACTIVITY OF THE IL-15/IL-15R ALFA COMBINATION IN AN EXPERIMENTAL MODEL OF MELANOMA
    Isvoranu, Gheorghita
    Marinescu, B.
    Surcel, Mihaela
    Ursaciuc, C.
    Manda, Gina
    FARMACIA, 2015, 63 (05) : 631 - 636
  • [35] A 3D QSAR Study of Betulinic Acid Derivatives as Anti-Tumor Agents Using Topomer CoMFA: Model Building Studies and Experimental Verification
    Ding, Weimin
    Sun, Miao
    Luo, Shaman
    Xu, Tao
    Cao, Yibo
    Yan, Xiufeng
    Wang, Yang
    MOLECULES, 2013, 18 (09) : 10228 - 10241
  • [36] Anti-Tumor Potential of a 5-HT3 Receptor Antagonist as a Novel Autophagy Inducer in Lung Cancer: A Retrospective Clinical Study with In Vitro Confirmation
    Lee, Jeong Soo
    Park, Seong Yong
    Kim, Na Young
    Kim, Dong Wook
    Oh, Ju Eun
    Heo, Eunjin
    Lee, Jong Seok
    Yoo, Young Chul
    JOURNAL OF CLINICAL MEDICINE, 2019, 8 (09)
  • [37] An exhaustive pre-clinical study of a circRNA drug candidate (cmRNA1210) encoding IL-12sc for anti-tumor therapeutics.
    Wang, Shuhang
    Yang, Jiali
    Wei, Lixiang
    Tan, Yiling
    Sun, Jiaojiao
    Wu, Fan
    Huang, Lingkun
    Ma, Peiwen
    Zhou, Jiawei
    Zhao, Guo
    Wang, Yuning
    Tang, Qiyu
    Zuo, Chijian
    Li, Ning
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [38] X-RAY STRUCTURAL STUDY OF 3',6'-0-(1,1,3,3-TETRAISOPROPYL-1,3-DISILOXANEDIYL)-NEPLANOCIN A, A DERIVATIVE OF A NOVEL ANTI-TUMOR ANTIBIOTIC
    YAMAZAKI, M
    HAMADA, K
    YAMAGATA, Y
    FUJIWARA, T
    TOMITA, KI
    FUKUKAWA, K
    UEDA, T
    HIRANO, T
    ACTA CRYSTALLOGRAPHICA SECTION B-STRUCTURAL SCIENCE, 1982, 38 (APR): : 1176 - 1180
  • [39] ABN401 demonstrates robust anti-tumor efficacy in orthotopic PDX models of MET-driven NSCLC brain metastases in a pre-clinical study
    Rajasekaran, Nirmal
    Park, Kyung Eui
    Lee, Saehyung
    Kim, Na Young
    Chung, Suk-Jae
    Shin, Young Kee
    Choi, Jun Young
    CANCER RESEARCH, 2023, 83 (07)
  • [40] Confirmation of target inhibition and anti-tumor activity of the SHP2 inhibitor RMC-4630 via longitudinal analysis of ctDNA in a phase 1 clinical study.
    Hayes, Josie L.
    Koczywas, Marianna
    Ou, Sai-Hong Ignatius
    Janne, Pasi A.
    Pacheco, Jose M.
    Ulahannan, Susanna
    Wang, Judy S.
    Burris, Howard A.
    Riess, Jonathan W.
    McCoach, Caroline
    Gordon, Michael S.
    Capasso, Anna
    Chen, Ariel
    Dua, Richa
    Bitman, Bojena
    Guerra, Martha
    Wang, Hongfang
    Wang, Xiaolin
    Haura, Eric
    CANCER RESEARCH, 2021, 81 (13)
12345